Clinical Trials Browser

Interventional × Brain Neoplasms × repotrectinib × Clear all

NCT06315010 2026-02-25

REPOSE

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung